Exam 2 - Nelson Material Flashcards

1
Q

How is celexocib related to prostaglandins?

A
  • Selective COX-2 inhibitor –> inhibits formation of prostaglandins from arachidonic acid
  • Decreases downstream inflammatory prostaglandins
  • Treatment of rheumatoid arthritis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How is latanaprost related to prostaglandins?

A
  • PGF2a analog
  • lipophilic so it can penetrate cornea
  • decreases production of aqueous humor –> reduces intraocular pressure
  • Treatment of ocular hypertension/glaucoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the use and MOA of anakinra?

A

Interleukin receptor antagonist (IL-IRa)

  • competitively inhibits IL-1 from binding and causing inflammation
  • used in rheumatoid arthritis to reduce inflammation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the use and MOA of etanercept?

A

Soluble fusion protein

  • tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1
  • binds to TNF-alpha and “sequesters” it –> leads to decreased inflammation downstream
  • used in rheumatoid arthritis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the use and MOA of Brilinta (ticagrelor)?

A

ADP analog

  • competitively inhbits ADP from binding to P2y12 receptor in platelets, which would initiate clotting
  • used as an anti-thrombotic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the use and MOA of aspirin (hemetologic)?

A

COX-1 inhibitor

  • irreversibly inhibits COX-1 by acetylating a serine residue
  • inhibits formation of PGH2 (which is converted to TXA2 and initiates clotting)
  • used to prevent blood clots in patients at risk
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the ligand/substrate for the activated GPIIb/IIIa receptor? Why is inhibition therapeutically useful?

A
  • The activated form binds fibrinogen
  • When bound, the fibrinogen can form cross-links between platelets via fibrinogen-fibrinogen or fibrinogen-VWF
  • Inhibition of fibrinogen prevents cross-links and prevents platelet aggregation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the ligand/substrate for COX-2? Why is inhibition therapeutically useful?

A
  • Binds arachadonic acid, converts it to PG-G2
  • Implicated in the proinflammatory response and associated with pain
  • Inhibition reduces inflammation and pain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the ligand/substrate for the P2Y12 receptor? Why is inhibition therapeutically useful?

A
  • Binds ADP and other purines
  • A component of ADP-mediated platelet aggregation
  • Inhibition leads to less ADP induced platelet-fibrinogen binding and less platelet aggregation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the ligand/substrate for xanthine oxidase? Why is inhibition therapeutically useful?

A
  • Oxidizes hypoxanthing to xanthine and uric acid
  • Uric acid (in form of sodium urate) can precipitate and form crystals that deposit in joints in gout, leading to inflammation
  • Inhibition prevents the formation of the sodium urate and is a treatment for gout
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the ligand/substrate for COX-1? Why is inhibition therapeutically useful?

A
  • COX-1 converts arachidonic acid –> prostaglandin –> TXA2, which induces platelet aggregation
  • Inhibition of COX-1 in platelets lowers TXA2 levels and prevents activation of GPIIb/IIIa, which leads to less platelet aggregation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the therapeutic use and MOA of adalimumab (Humira)?

A
  • human MAB specific for TNF-alpha

- prevents TNF-alpha mediated inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How is clopidogrel used and thought to work?

A
  • Oxidation of the thiopene ring yields a ring-open (active) metabolite
  • The active metabolite binds to cys 97 of the P2Y12 receptor, which normally binds ADP and induces platelet aggregation
  • The covalent bond prevents platelet aggregation
  • Used as an anti-thrombolytic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How is tirofiban used and thought to work?

A
  • Competitive antagonist of the GPIIb/IIIa receptor
  • Modeled to occupy binding site for Arg-GLy-Asp area of fibrinogen
  • Prevents fibrinogen binding, and formation of platelet plug
  • Used in acute coronary syndrome, coronary angioplasty
How well did you know this?
1
Not at all
2
3
4
5
Perfectly